Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.69 |
| ▸ | RAB9A | P51151 | 3/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 8/20 | 0.65 |
| ▸ | MAOA | P21397 | 1/20 | 0.65 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.63 |
| ▸ | RELA | Q04206 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL691132 | 1.00 | NPC1 (0.69) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL8023969 | 0.98 | NPC1 (0.68) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL27766810 | 0.88 | NPC1 (0.60) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| Diethanolamine SCHEMBL5054343 | 0.88 | KDM4E (0.57) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| Diethanolamine SCHEMBL5054345 | 0.88 | KDM4E (0.57) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL9556747 | 0.87 | NPC1 (0.56) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL7969488 | 0.87 | KDM4E (0.73) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL7969484 | 0.87 | KDM4E (0.73) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL417823 | 0.86 | ABCG2 (0.65) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL154581 | 0.86 | ABCG2 (0.65) | KMT2APOLBTHRBATMABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328938-B1 | RADICALLY FUNCTIONALIZED OLEFIN-BASED POLYMER WITH REDUCED MOLECULAR WEIGHT CHANGE AND METHOD | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-01 | — | — | EP | claimed |
| US-5961875-A | Antifreeze/coolant composition containing cinnamic acid | CCI CO., LTD. (JP) | 1999-10-05 | — | — | US | claimed |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | SUMITOMO CHEMICAL CO (JP) | 2026-01-01 | — | — | US | disclosed |
| EP-4578895-A1 | POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-07-02 | — | — | EP | disclosed |
| EP-4578894-A1 | HYDROPHILIC OIL REPELLENT POLYMER | Sumitomo Chemical Company, Limited (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-119604562-A | Hydrophilic oil-repellent polymer | 住友化学株式会社 | 2025-03-11 | — | — | CN | disclosed |
| US-11999695-B2 | YAP1 inhibitors that target the interaction of YAP1 with OCT4 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| CN-114746154-B | Cosmetic composition, use thereof and method for improving organoleptic properties | 巴斯夫欧洲公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024043326-A1 | HYDROPHILIC OIL REPELLENT POLYMER | 住友化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| WO-2024043327-A1 | POLYMER, RESIN COMPOSITION, MOLDED BODY, AND POLYMER PRODUCTION METHOD | 住友化学株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-20230234924-A1 | YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2023-07-27 | — | — | US | disclosed |
| EP-0590919-A1 | Therapeutic agents for parkinson's disease | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1994-04-06 | — | — | EP | disclosed |
| EP-0565377-A1 | Therapeutic agents for use in the treatment of parkinson's disease | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1993-10-13 | — | — | EP | disclosed |
| US-RE32944-E | Aromatic carboxylic amide derivatives | Kissei Yakuhin Kogyo Kabushiki (JP) | 1989-06-06 | — | — | US | disclosed |
| US-4189484-A | Antihypertensive quinazoline derivatives | MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) | 1980-02-19 | — | — | US | disclosed |
| US-4070484-A | Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same | KISSEI PHARMACEUTICAL CO., LTD. (JA) | 1978-01-24 | — | — | US | disclosed |
| US-4026896-A | ANTIALLERGENS | KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (KISSEI PHARMACEUTICAL CO. LTD.) (JA) | 1977-05-31 | — | — | US | disclosed |
| US-3995054-A | MITICIDES | ZOECON CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
| US-3975429-A | Cyclopropanemethyl esters of cinnamic acid and derivatives thereof | ZOECON CORPORATION (US) | 1976-08-17 | — | — | US | disclosed |
| US-3940422-A | ANTIALLERGEN | KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (JA) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11999695-B2 | YAP1 inhibitors that target the interaction of YAP1 with OCT4 | YAP1, YES1, MYC | NPC1 4862/4885RAB9A 2213/4885KDM4E 586/4885 |
| US-20260001999-A1 | HYDROPHILIC OIL REPELLENT POLYMER | CCR1, H1-3, CCR3 | NPC1 265/4885RAB9A 3950/4885KDM4E 3780/4885 |
| US-20230234924-A1 | YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 | YAP1, YES1, MYC | NPC1 4862/4885RAB9A 2213/4885KDM4E 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.